1. Home
  2. NEO vs LU Comparison

NEO vs LU Comparison

Compare NEO & LU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • LU
  • Stock Information
  • Founded
  • NEO 2001
  • LU 2005
  • Country
  • NEO United States
  • LU China
  • Employees
  • NEO N/A
  • LU N/A
  • Industry
  • NEO Precision Instruments
  • LU Finance: Consumer Services
  • Sector
  • NEO Health Care
  • LU Finance
  • Exchange
  • NEO Nasdaq
  • LU Nasdaq
  • Market Cap
  • NEO 1.9B
  • LU 2.4B
  • IPO Year
  • NEO 1999
  • LU 2020
  • Fundamental
  • Price
  • NEO $14.11
  • LU $2.38
  • Analyst Decision
  • NEO Strong Buy
  • LU Hold
  • Analyst Count
  • NEO 10
  • LU 2
  • Target Price
  • NEO $20.44
  • LU $2.98
  • AVG Volume (30 Days)
  • NEO 1.2M
  • LU 3.0M
  • Earning Date
  • NEO 02-18-2025
  • LU 03-20-2025
  • Dividend Yield
  • NEO N/A
  • LU 97.13%
  • EPS Growth
  • NEO N/A
  • LU N/A
  • EPS
  • NEO N/A
  • LU N/A
  • Revenue
  • NEO $644,118,000.00
  • LU $4,671,260,668.00
  • Revenue This Year
  • NEO $13.00
  • LU N/A
  • Revenue Next Year
  • NEO $10.10
  • LU $1.48
  • P/E Ratio
  • NEO N/A
  • LU N/A
  • Revenue Growth
  • NEO 12.06
  • LU N/A
  • 52 Week Low
  • NEO $12.13
  • LU $2.00
  • 52 Week High
  • NEO $19.11
  • LU $4.94
  • Technical
  • Relative Strength Index (RSI)
  • NEO 40.08
  • LU 45.94
  • Support Level
  • NEO $13.76
  • LU $2.26
  • Resistance Level
  • NEO $15.26
  • LU $2.49
  • Average True Range (ATR)
  • NEO 0.68
  • LU 0.14
  • MACD
  • NEO -0.02
  • LU -0.02
  • Stochastic Oscillator
  • NEO 7.85
  • LU 18.66

About NEO NeoGenomics Inc.

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

About LU Lufax Holding Ltd each representing two (2)

Lufax Holding Ltd is a technology-empowered personal financial services platform in China. The company address the large unmet demand for personal lending among small business owners as well as salaried workers in China and provides tailor-made wealth management solutions to China's middle class and affluent population. Its platform has two hubs namely Retail Credit Facilitation Hub and Wealth Management Hub.

Share on Social Networks: